Joel S. Hirschhorn, PhD<\/p>\n
What most people have heard about deaths and illness caused by COVID vaccines is just the tip of the iceberg. Medical research articles keep rolling out on a host of health impacts from the vaccines. Here a number of new articles are cited to better reveal how unsafe the vaccines are.<\/p>\n
An important part of the message for the general population should be this. All the new research on vaccine impacts comes from just two years of vaccine use. Thus we still do not have good information on the long term health impacts. There is a reasonable probability that the negative health impacts will become even worse as more time for impacts on bodies and for research increases.<\/p>\n
Another point is that even though the percent of people impacted may seem quite low it is important to remember that there are huge numbers of people vaccinated, hundreds of million people. This means that very large numbers of people may be impacted by a host of diseases that at first seem minor<\/p>\n
Lastly, it is possible that some people may become victims of several vaccine caused health problems.. Juat another factor to consider when high excess death rates continue to be observed nearly everywhere.<\/p>\n
There has been limited analysis and data on cancers being caused by the COVID mRNA vaccines. Now comes a creative new analysis by Ronald Kostoff. The article title is: ARE COVID-19 VACCINE-INDUCED CANCERS RARE EVENTS?<\/a><\/p>\n Here is one statement that caught my attention: “Applying the URF [unreported fraction] of ~100 from the Harvard Pilgrim Health Care study, and the 1\/3 fraction from the autopsy results to the post-COVID-19 vaccine VAERS cancer-related numbers yields a total of about 83,000 cancer-related events post-COVID-19 vaccination (so far).”<\/p>\n Here are a few excerpts:<\/p>\n COVID-19 vaccine-induced cancer has been judged a \u201crare\u201d event by the major promoters of these vaccines (caveat: these injections prevent neither infection nor viral transmission, so they are not vaccines in the classical sense).\u00a0 To ascertain the frequency of COVID-19 vaccine-induced cancers, we have examined the Vaccine Adverse Events Reporting System (VAERS) database for reports of cancers.\u00a0 Since cancers tend to have a long latency period, we have also addressed the issue of Early Warning Indicators that could identify COVID-19 vaccine-induced cancers on or over the horizon.\u00a0 Finally, we have compared cancers reported following COVID-19 vaccines with those reported following influenza vaccines for similar numbers of vaccine doses delivered.<\/p>\n While imperfect (as are most publicly-available vaccine adverse events reporting systems), VAERS is a reasonable system for identifying safety signals related to vaccines.\u00a0 One major VAERS deficiency is that only a small fraction of vaccine-related adverse events is reported to VAERS.\u00a0 A study by Harvard Pilgrim Health Care<\/a>, using electronic tracking, showed that \u201cfewer than 1% of vaccine adverse events are reported\u201d.\u00a0 This is an average value over all adverse events; it may be far worse for cancer.<\/p>\n Before presenting the numbers, we need to define what is a cancer-related event reported in VAERS.\u00a0 Is it 1) a biomarker associated with the eventual emergence of cancer, 2) a group of biomarkers reflecting pre-clinical cancer, 3) a newly-diagnosed cancer, 4) a cancer that has been exacerbated, or 5) a cancer death? While all five are valid candidates, the present study concentrates on items 3) and 4).<\/p>\n This restriction to items 3) and 4) substantially under-reports the COVID-19 vaccine adverse events that may eventually result in cancer, because it excludes abnormalities in cancer risk biomarkers.<\/em><\/p>\n There were ~330 different cancer-related adverse events reported in VAERS for the COVID-19 vaccines, with ~2500 total number of events.\u00a0 Converting these VAERS entries to real-world numbers of COVID-19 vaccine-induced cancers requires three major assumptions, and some minor ones.\u00a0 The major assumptions are 1) the cancers reported in VAERS following the administration of COVID-19 vaccines are in fact caused in part or in whole by the COVID-19 vaccines, 2) the under-reporting factor (URF) to be used for cancer scale-up to real-world numbers can be approximated for very conservative estimation purposes by the Harvard Pilgrim Healthcare URFs, and 3) the fraction of the VAERS entries to which the URF should be applied can be approximated by autopsy results for fraction of post-COVID-19 vaccine deaths that can be attributed to the COVID-19 vaccine.<\/p>\n Assumption 1) is based on mechanistic studies<\/a> that show the COVID-19 mRNA vaccines (those distributed most widely in the USA) destroy the innate immune system, including those components that surveille and control the growth of cancers.\u00a0 One of the specific mechanisms demonstrated in very recent mechanistic studies (https:\/\/www.science.org\/doi\/ Assumption 3) is based on the observation that autopsy results for COVID-19 vaccine-induced deaths showed about 1\/3 of all the VAERS entries for deaths could be attributed to the vaccine<\/a>. Whether this fraction is applicable to vaccine-induced cancer is unknown.<\/p>\n All the major cancers are represented, with breast, lung, prostate, brain, and colon cancers being the most frequent.\u00a0 Placing these results in context is a separate study in itself.\u00a0 We do a simple comparison of the highest frequency cancers reported here with their counterparts for the influenza vaccines reported in VAERS.\u00a0 We selected influenza, since it is a respiratory viral disease and has a number of features in common with COVID-19.<\/p>\n A very innovative analysis is presented in the new article: Age-stratified COVID-19 vaccine-dose fatality rate for Israel and Australia.<\/a> What is noteworthy is that the detailed analysis for Israel and Australia leads to a generalization applicable to the United States. The paper points out that \u201cit is not unreasonable to assume an all-population global value of vDFR = 0.1 % [vaccine dose fatality rate]\u201d This is for vaccine doses. <\/strong>For the US, 670M doses have been given, so the estimate is 670,000 people have been killed by the COVID vaccines in the US.<\/p>\n Here are a few excerpts:<\/p>\n It is well established that the COVID-19 vaccines can cause death, as seen from detailed autopsy studies (Choi et al., 2021; Schneider et al., 2021; Sessa et al., 2021; Gill et al., 2022; M\u00f6rz, 2022; Schwab et al., 2022; Suzuki et al., 2022; Tan et al., 2022; Yoshimura et al., 2022; Onishi et al., 2023), adverse effect monitoring (Hickey and Rancourt, 2022), a recent survey study (Skidmore, 2023), studies of vaccine-induced pathologies (e.g., Goldman et al., 2021; Kuvandik et al., 2021; Turni and Lefringhausen, 2022; Edmonds et al., 2023; Wong et al., 2023), and more than 1,250 peer-reviewed publications about COVID-19 vaccine adverse effects (React 19, 2022).<\/p>\n In particular, a study of the Vaccine Adverse Event Reporting System (VAERS) data for the USA showed that the COVID-19 injections can be understood as individual challenges to the body, and that \u201ctoxicity by dose\u201d is a good first-order model of the phenomenon for the adverse effect of death (Hickey and Rancourt, 2022). An exponential increase of lethality with median age of those dying following injection was observed (Hickey and Rancourt, 2022).<\/p>\n Our all-population value of vDFR of approximately 0.05 % (Figure 3, Tables 1 and 2) implies that in the USA, following the administration of approximately 670 million COVID-19 vaccine doses to date (669.60 million doses, up to January 31, 2023, Our World in Data),2 approximately 330,000 USA residents would have died from the <\/strong><\/em>COVID-19 vaccine<\/strong><\/em>s (1 in 1,000 on a population basis), assuming that elderly and vulnerable individuals are not more abundant or more aggressively targeted than in Australia or Israel. This number is comparable to the 278,000 fatalities found by Skidmore (2023) in his survey study for the USA. Our number of 330,000 is probably an underestimate, in light of the exponential dependence of vDFR with age that we have demonstrated and the known exceptionally large pools of highly vulnerable residents in the USA (Rancourt et al., 2022b).<\/p>\n \u2026it is not unreasonable to assume an all-population global value of vDFR = 0.1 %. Based on the global number of COVID-19 vaccine doses administered to date (13.25 billion doses, up to January 24, 2023, Our World in Data),3 this would correspond to 13 million deaths from the COVID-19 vaccines worldwide.<\/strong><\/em><\/p>\n Two medical research articles presented evidence for vaccine caused psychosis.<\/p>\n The title of the first article is: Can new onset psychosis occur after mRNA based COVID-19 vaccine administration? A case report.<\/a><\/p>\n Here is a key part of the article:<\/p>\n A 31-year-old, single Hispanic male without past medical or psychiatric history, was brought to the emergency room by police because of erratic and bizarre behavior. He was found to be anxious, guarded, superficial and grandiose. He reported becoming \u2018clairvoyant\u2019, being able to talk with dead people, hearing \u2018people drumming outside his house\u2019 and the constant voice of a co-worker whom he believed to be a paramour- it was later confirmed that there was no romantic relationship. All these symptoms began one month ago, after receiving the first dose of an mRNA-based COVID-19 vaccine, and markedly worsened three weeks later after receiving the second dose. Previously, he was asymptomatic, working full-time as an office manager. Although functional in adolescence and adulthood, he described himself as a loner, with an inclination to overly spiritual ideas, and able to communicate directly with God. He had a few close friends and romantic relationships.<\/p>\n His-vital signs, blood chemistry, urine toxicology, urinalysis and chest radiograph were within normal limits, except for moderate leukocytosis with left shift, and erythrocyte sedimentation rate of 48\u00a0mm\/h. His-COVID-19 PCR was negative. Non-contrast head computerized tomography with- and without-contrast showed hyperintensities throughout the subcortical and periventricular white matter. Magnetic resonance imaging (MRI) also revealed focus of FLAIR hyperintensity in the left peritrigonal white matter, with multiple nonspecific punctate hyperintensities throughout the subcortical and periventricular white matter and focus of susceptibility in the right lateral thalamus. The patient was admitted to the neurology service, where a video electroencephalogram (EEG) was negative. He refused a lumbar puncture. The following day he was wandering the unit talking to himself, stating that the \u2018EEG machine was communicating with him\u2019. The patient demonstrated poor insight into his symptoms. He was started on risperidone 0.5\u00a0mg po qhs and placed on one-to-one observation. The next day, risperidone was increased to 0.5\u00a0mg qam and 1\u00a0mg qhs, and the patient was transferred to the psychiatric ward. He engaged in milieu treatment, and the hallucinations and delusions resolved after two days. He was discharged on the same medication regime five days later, with good insight about his symptoms. One week after discharge he was taking medication, asymptomatic and back to work.<\/p>\n This is the first report of psychotic symptoms after receiving a COVID-19 vaccine. SAR-CoV- 2 is known to trigger a powerful immune response, which includes the release of large amounts of proinflammatory cytokines. As of January 2021, 42 cases of psychosis associated with COVID-19 infection have been reported. It has been hypothesized that a COVID-19 triggered cytokine storm may increase the risk of psychosis. Coincidentally, schizophrenia has been linked to a pro-inflammatory status (Goldsmith\u00a0et\u00a0al., 2016<\/a>).<\/p>\n The title of the second paper is: FIRST EPISODE OF PSYCHOSIS FOLLOWING Here is the key summary:<\/p>\n CONCLUSION The title of this article is: Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights.<\/a><\/p>\n Here is the abstract:<\/p>\n Introduction: Varicella zoster virus (VZV) reactivation has been reported following vaccination for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the real extent remains unknown. Methods: We conducted a systematic review to summarize evidence of VZV reactivation or infection following SARS-CoV-2 vaccination. Episodes after coronavirus disease-2019 (COVID-19) were also identified. Related articles were identified in PubMed and EMBASE databases till December 31, 2021 using the terms \u201cvaricella zoster\u201d and \u201cCOVID-19\u2032\u2032 . The title of this article is: Reported cases of multisystem inflammatory syndrome in children aged 12\u201320 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.<\/a><\/p>\n Here are parts of the summary:<\/p>\n Here, we describe a small number of individuals with MIS-C who had received one or more doses of a COVID-19 vaccine before illness onset; the contribution of vaccination to these illnesses is unknown. Our findings suggest that MIS-C after COVID-19 vaccination is rare. Continued reporting of potential cases and surveillance for MIS-C illnesses after COVID-19 vaccination is warranted.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\nNew estimate of vaccine deaths<\/h1>\n
Psychosis<\/code><\/h1>\n
\nTHE COVID-19 VACCINATION – A CASE SERIES.<\/a><\/p>\n
\nWe report the case series of three patients who de-
\nveloped psychotic symptoms after the COVID-19
\nvaccination. Considering the evidence in the literature
\nof an association between altered immune function and
\npsychosis, the negative family and personal psychiatric
\nhistory of our patients, the clinical presentation, and the
\nclose temporal relationship between the COVID-19
\nvaccination and the presenting symptoms, we hypo-
\nthesise that the COVID-19 vaccine may play a role in
\nthe aetiology of their symptoms. Since the COVID-19
\nvaccine has been shown to be safe and effective
\n(Sultana et al. 2022), and the development of psycho-
\nsis after vaccination is very rare (Reinfeld et al. 2021),
\nwe firmly believe that this case series should not
\ndiscourage the use of the COVID-19 vaccine. Rather,
\nfuture systematic studies should be conducted with
\nadequate control of confounding variables to establish
\ncoincidence, association or causality between reported
\npsychotic symptoms and the COVID-19 vaccine.<\/p>\nShingles<\/h1>\n
\nResults: The search revealed 314 articles, of which 55 met the inclusion criteria. VZV manifestations were documented in 179 (82.1%) subjects following SARS-CoV-2 vaccination and in 39 (17.9%) patients with COVID-19. Among the vaccinated, median (IQR) age was 56.5 (42\u201370) years, and 56.8% were female. Twenty-one (16.8%) were immunosuppressed. The median (IQR) latency time after vaccination was 6 (3\u201310) days, and 84.4% received mRNA vaccines. VZV reactivation occurred following a first dose (68.2%), a second dose (12.8%) or a booster (0.6%). The most important VZV manifestation was dermatome herpes zoster rash, which accounted for 86.4% of events in vaccinated subjects. Twenty patients (11.3%) presented serious VZV events after vaccination, with Herpes Zoster ophthalmicus (5.6%) and post-herpetic neuralgia (3.4%) predominating. No VZV pneumonia or deaths were recorded. Antiviral prescriptions were made in 96.2% of vaccinated subjects. No significant differences between vaccinated and infected subjects were found. Conclusion: This study indicates that the occurrence of VZV reactivation is clinically relevant.<\/p>\nMultisystem inflammatory syndrome<\/h1>\n
Background<\/h3>\n
Findings<\/h3>\n
Interpretation<\/h3>\n